sick times
-
A new aid in the doctor’s office: Introducing the Long COVID Treatment Guide
Too often, people with Long COVID hear that since clinical research is still underway, not much can be done for them at this point. We at the Patient-Led Research Collaborative and RTHM Clinic reject this narrative. We collaborated to create a treatment guide.
-
Comic: Reasons to wear a mask in 2026
Artist Gillian Levine recently wrote and illustrated a comic sharing reasons to continue masking in 2026.
-
Event announcement: The Long COVID op-ed
Help break the stigma around Long COVID by sharing your story with the public. In this free webinar on February 19, The Sick Times editors and guest speakers will demystify the process of writing and pitching op-eds and essays on Long COVID.
-
Editor’s note: An update on a recent book excerpt
Last week, we published a short excerpt from a recently-released book. We decided to take down the excerpt.
-
Fundraiser results: Our work continues into 2026 with a new team member
We are excited to share some good news as we start off 2026: The Sick Times had a successful end-of-year fundraiser! Thank you to everyone who donated, shared, gave us feedback, or otherwise contributed to our campaign.
-
HHS hosts event and announces new initiatives for Lyme disease, but advocates are skeptical about follow-through
The Lyme disease roundtable followed a similar event on Long COVID, which still hasn’t led to action on the disease
-
International Long COVID conference spotlights biomarker and mechanism research
The event, now in its third year, also revealed updates about clinical trials and healthcare for the disease.
-
Live blog: PolyBio’s Fall 2025 Symposium shares Long COVID and related disease research updates
Leading Long COVID and related disease researchers are set to present updates to their work today at the PolyBio Research Foundation’s Fall 2025 Symposium. PolyBio supports some of the most highly-anticipated research projects in infection-associated chronic conditions (IACCs).
-
Vyvgart brought us back to life, but the Long COVID trial was canceled. We are calling on the NIH and HHS to study the drug.
We are a group of 53 individuals with Long COVID from across the U.S. In 2023, we joined a Long COVID clinical trial for Vyvgart (efgartigimod), a drug approved by the Food and Drug Administration (FDA) for the autoimmune disease myasthenia gravis. Without warning, the trial was canceled in June 2024.
-
Letter to the editors: Concerns about California’s right-to-mask bill
In May, The Sick Times published an op-ed about a novel bill in Illinois that would enshrine the right to wear medical masks into that state’s law. The op-ed’s author, a writer and advocate who was part of the coalition behind the bill, wrote that advocates in several other states had worked on similar legislation.…
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
A new aid in the doctor’s office: Introducing the Long COVID Treatment Guide
-
Where have all the Long COVID clinics gone?
-
National COVID-19 trends, March 10
-
Research updates, March 10
-
My child and I both have Long COVID. Even in COVID-aware spaces, we are excluded because of their pre-existing disability.
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance